PELUCCHI, SARA
 Distribuzione geografica
Continente #
NA - Nord America 5.594
EU - Europa 2.528
AS - Asia 1.223
SA - Sud America 130
AF - Africa 14
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 9.494
Nazione #
US - Stati Uniti d'America 5.500
DE - Germania 480
SG - Singapore 450
CN - Cina 440
IT - Italia 405
SE - Svezia 387
IE - Irlanda 327
RU - Federazione Russa 240
UA - Ucraina 215
GB - Regno Unito 155
HK - Hong Kong 134
BR - Brasile 115
CA - Canada 90
FI - Finlandia 72
AT - Austria 55
FR - Francia 49
IN - India 40
VN - Vietnam 38
NL - Olanda 36
BE - Belgio 33
TR - Turchia 33
DK - Danimarca 31
ID - Indonesia 29
JP - Giappone 11
IR - Iran 8
PK - Pakistan 7
CZ - Repubblica Ceca 6
KR - Corea 6
EC - Ecuador 5
LT - Lituania 5
PL - Polonia 5
RO - Romania 5
BG - Bulgaria 4
KG - Kirghizistan 4
MA - Marocco 4
UZ - Uzbekistan 4
AR - Argentina 3
AU - Australia 3
GR - Grecia 3
IQ - Iraq 3
MY - Malesia 3
VE - Venezuela 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
CO - Colombia 2
EG - Egitto 2
HR - Croazia 2
HU - Ungheria 2
KE - Kenya 2
MX - Messico 2
NG - Nigeria 2
OM - Oman 2
TH - Thailandia 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BO - Bolivia 1
CG - Congo 1
CH - Svizzera 1
DO - Repubblica Dominicana 1
ES - Italia 1
EU - Europa 1
GE - Georgia 1
IM - Isola di Man 1
IS - Islanda 1
LK - Sri Lanka 1
LV - Lettonia 1
MT - Malta 1
NZ - Nuova Zelanda 1
PE - Perù 1
PH - Filippine 1
RS - Serbia 1
SA - Arabia Saudita 1
SC - Seychelles 1
SV - El Salvador 1
TM - Turkmenistan 1
TN - Tunisia 1
ZM - Zambia 1
Totale 9.494
Città #
Ann Arbor 1.285
Woodbridge 556
Fairfield 446
Chandler 388
Houston 374
Frankfurt am Main 325
Dublin 315
Singapore 312
Ashburn 266
Wilmington 254
Jacksonville 235
Dearborn 186
Seattle 171
Cambridge 152
New York 139
Hong Kong 132
Milan 126
Santa Clara 115
Princeton 109
Nanjing 95
Shanghai 66
Lawrence 51
Vienna 51
Altamura 45
Lachine 40
San Diego 35
Brussels 29
Nanchang 28
Beijing 27
Dong Ket 26
Jakarta 25
Helsinki 24
Ottawa 24
Shenyang 24
Boardman 21
Tianjin 19
Turin 19
Council Bluffs 18
Hebei 18
Andover 17
Jiaxing 16
Jinan 15
Los Angeles 15
Toronto 14
Guangzhou 13
Zhengzhou 12
Changsha 11
Huizen 11
Munich 10
Pune 10
Fremont 9
Kocaeli 8
Ningbo 8
Nuremberg 8
Auburn Hills 7
Hangzhou 7
Lissone 7
Mountain View 7
Norwalk 7
Phoenix 7
Rio de Janeiro 7
Segrate 7
Taizhou 7
Hefei 6
Lecco 6
Monza 6
Philadelphia 6
Rome 6
San Francisco 6
São Paulo 6
Washington 6
Cinisello Balsamo 5
Desio 5
Edmonton 5
London 5
Meda 5
University Park 5
Bishkek 4
Bonndorf 4
Carate Brianza 4
Chiswick 4
Kunming 4
Quito 4
Sacramento 4
San Mateo 4
Seregno 4
Waanrode 4
Belo Horizonte 3
Bengaluru 3
Brasília 3
Ceret 3
Cesena 3
Chicago 3
Chongqing 3
Daejeon 3
Dallas 3
Falls Church 3
Lanzhou 3
Lappeenranta 3
Nürnberg 3
Totale 6.968
Nome #
Hepcidin regulation in a mouse model of acute hypoxia 404
Phenotypic heterogeneity in seven Italian cases of aceruloplasminemia 313
GNPAT rs11558492 is not a major modifier of iron status: Study of Italian hemochromatosis patients and blood donors 297
A severe hemojuvelin mutation leading to late onset of HFE2-hemochromatosis 267
Hif1a: A putative modifier of hemochromatosis 230
Inherited iron overload disorders 227
Hepcidin regulation in a mouse model of acute hypoxia 215
Hepcidin and iron-related gene expression in subjects with Dysmetabolic Hepatic Iron Overload 210
Genetic and metabolic factors are associated with increased hepatic iron stores in a selected population of p.Cys282Tyr heterozygotes 210
Type 3 hemochromatosis and beta-thalassemia trait 205
Expression of hepcidin and other iron-related genes in type 3 hemochromatosis due to a novel mutation in transferrin receptor-2. 203
Transferrin receptor 2 mutations in patients with juvenile hemochromatosis phenotype 203
Does aceruloplasminemia modulate iron phenotype in thalassemia intermedia? 196
Circulating factors are involved in hypoxia-induced hepcidin suppression 195
Unexplained isolated hyperferritinemia without iron overload 193
Reduced expression of hepcidin in patients with myelodysplastic syndrome and myelofibrosis: the causes might be more heterogeneous than in thalassaemia. 190
Prolonged exposure to welding fumes as a novel cause of systemic iron overload 190
Novel mutations of the ferroportin gene (SLC40A1): Analysis of 56 consecutive patients with unexplained iron overload 184
Patients with chronic hepatitis C may be more sensitive to iron hepatotoxicity than patients with HEF-Hemochromatosis 173
CYBRD1 as a modifier gene that modulates iron phenotype in HFE p.C282Y homozygous patients 173
Heterogeneity of iron overload: Clinical, biochemical, histopathologic and genetic study of 70 patients 170
Dysmetabolic Hepatic Iron Overload Syndrome: Analysis of Hepcidin Response to Acute Oral Iron and Chronic Iron Overload 170
Ferroportin disease: A novel SLC40A1 mutation 169
Hepcidin expression in iron overload diseases is variably modulated by circulating factors 168
Atypical phenotype in a patient with ceruloplasmin mutations in the compound heterozygous state 168
A time course of hepcidin response to oral iron challenge in hfe and tfr2 hemochromatosis patients 168
Homozygous deletion of HFE: The Sardinian hemochromatosis? 166
Hepcidin response to acute iron intake and chronic iron loading in dysmetabolic iron overload syndrome 166
Proprotein convertase 7 rs236918 associated with liver fibrosis in Italian patients with HFE-related hemochromatosis 165
Measurement of serum hepcidin-25 levels as a potential test for diagnosing hemochromatosis and related disorders 158
Simultaneous liver iron and fat measures by magnetic resonance imaging in patients with hyperferritinemia 153
IRON AND HYPOXIA LINK: DOWNREGULATION OF LUCIFERASE ACTIVITY OF HEPCIDIN PROMOTER BY HYPOXIC SERA IN HUH-7 CELLS 151
UNEXPLAINED ISOLATED HYPERFERRITINEMIA IN PATIENTS WITHOUT MUTATIONS IN FERRITIN GENE AND L-FERRITIN IRES REGIONS 150
HFE and SLC40A1 polymorphisms in patients with unexplained iron overload 150
Analysis of Polymorphisms of Genes Regulating Hepcidin Transcription in Hfe-Hemochromatosis 150
Modulation of hepcidin production during hypoxia-induced erythropoiesis in humans in vivo: data from the HIGHCARE project 149
Iron chelation therapy in aceruloplasminaemia: study of a patient with a novel missense mutation 149
Total iron-overload measurement in the human liver region by the magnetic iron detector. 147
Prevalence of C282Y and E168X HFE mutations in an italian population of northern european ancestry 143
The iron-hypoxia link: hepcidin has a central role in the response to acute and chronic exposure to hypobaric hypoxia. data from the highcare project 141
Patatin-like phospholipase domain containing-3 gene I148M polymorphism, steatosis, and liver damage in hereditary hemochromatosis 140
A time course of hepcidin response to iron challenge in patients with HFE and TFR2 hemochromatosis 138
Homozygosity for transferrin receptor-2 y250x mutation induces early iron overload 136
GNPAT rs11558492 is not associated to iron overload in Italian HFE p.C282Y homozygotes 135
Genome-wide association study identifies TF as a significant modifier gene of iron metabolism in HFE hemochromatosis 130
Erythrocytapheresis plus erythropoietin: An alternative therapy for selected patients with hemochromatosis and severe organ damage 129
Single breath-hold multiecho mri sequences (at 1.5t) for the simultaneous lipid quantification and t2*measurement in patients with increased serum ferritin levels 129
Idiopathic erythrocytosis: a germline disease? 123
Interaction Between the PNPLA3 I148M Mutation, Body Weight, And Steatosis, In Determining The Progression To Cirrhosis In Hereditary Hemochromatosis 122
Ceruloplasmin variants might have different effects in different iron overload disorders 122
Identification of novel mutations by targeted NGS panel in patients with hyperferritinemia 119
Gene symbol: FTL. Disease: Hyperferritinemia-cataract syndrome 104
Interaction between the PNPLA3 I148M mutation and body weight in determining steatosis and the progression to cirrhosis in hereditary hemochromatosis 98
Intravenous iron therapy improves the hypercapnic ventilatory response and sleep disordered breathing in chronic heart failure 86
Hypoxia-dependent hepcidin down-regulation: an in vitro study 83
Clinical and Molecular features of the patients with Idiopathic Erythrocytosis 78
Paired Exome Sequencing Reveals Recurrent Germline Variants in Patients with Idiopathic Erythrocytosis 73
Angiotensin type 2 and mas receptor activation prevents myocardial fibrosis and hypertrophy through the reduction of inflammatory cell infiltration and local sympathetic activity in angiotensin ii‐dependent hypertension 71
Hereditary Hyperferritinemia 55
Cardioprotective Effects of Sodium Glucose Cotransporter 2 Inhibition in Angiotensin II-Dependent Hypertension Are Mediated by the Local Reduction of Sympathetic Activity and Inflammation 49
Reference Values of Ceruloplasmin across the Adult Age Range in a Large Italian Healthy Population 29
Prognostic Biomarkers in Breast Cancer via Multi-Omics Clustering Analysis 25
Totale 9.803
Categoria #
all - tutte 34.869
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.869


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020224 0 0 0 0 0 0 0 0 0 87 113 24
2020/20211.116 79 46 113 120 81 84 86 71 98 136 84 118
2021/2022960 61 93 106 76 70 56 62 51 40 74 81 190
2022/20231.529 205 429 155 156 101 222 10 84 95 10 30 32
2023/2024982 40 48 43 45 107 272 194 50 42 15 18 108
2024/20251.386 122 193 114 91 238 104 132 110 261 21 0 0
Totale 9.803